Hoth Therapeutics Stock Investor Sentiment

HOTH Stock  USD 1.11  0.02  1.83%   
Under 50% of Hoth Therapeutics' traders are presently thinking to get in. The analysis of overall sentiment of trading Hoth Therapeutics stock suggests that some investors are interested at this time. Hoth Therapeutics' investing sentiment shows overall attitude of investors towards Hoth Therapeutics.
  

Hoth Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Hoth Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at news.google.com         
Hoth Therapeutics Receives Buy Rating from D. Boral Capital - Defense World
Google News at Macroaxis
six days ago at finance.yahoo.com         
Hoth Therapeutics Announces Plans to Submit Expanded Access Application for HT-001 to Support Cancer...
Yahoo News
six days ago at thelincolnianonline.com         
D. Boral Capital Reaffirms Buy Rating for Hoth Therapeutics
news
over a week ago at finance.yahoo.com         
Hoth Therapeutics Announces Positive Results for HT-001 in Treating EGFR Inhibitor-Associated Papulo...
Yahoo News
over a week ago at finance.yahoo.com         
Hoth Therapeutics Announces Positive Findings on GDNFs Potential as a Game-Changer in Obesity Treatm...
Yahoo News
over a week ago at thelincolnianonline.com         
Hoth Therapeutics, Inc. Short Interest Update
news
over two weeks ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over three weeks ago at www.macroaxis.com         
Acquisition by Springer Graig of 33000 shares of Hoth Therapeutics at 2.11 subject to Rule 16b-3
Macroaxis News
over a month ago at thelincolnianonline.com         
Acquisition by Hayes Anthony of 35000 shares of Hoth Therapeutics at 5.26 subject to Rule 16b-3
news
over a month ago at finance.yahoo.com         
Hoth Therapeutics Partners with OnTargetx RD to Advance Research for Cancer fighting HT-KIT Cancer T...
Yahoo News
over a month ago at news.google.com         
Hoth Therapeutics expands at-the-market offering by 5 million - Investing.com UK
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements
Yahoo News
over a month ago at news.google.com         
Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements - PR Newswire
Google News at Macroaxis
over a month ago at seekingalpha.com         
Hoth Therapeutics regains compliance with Nasdaq
seekingalpha News
over a month ago at finance.yahoo.com         
Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Application...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Hoth Therapeutics that are available to investors today. That information is available publicly through Hoth media outlets and privately through word of mouth or via Hoth internal channels. However, regardless of the origin, that massive amount of Hoth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hoth Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hoth Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hoth Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hoth Therapeutics alpha.

Hoth Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of tradable shares by Hayes Anthony of Hoth Therapeutics subject to Rule 16b-3
12/20/2024
2
Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment
12/26/2024
3
Hoth Therapeutics Soars 215 percent on Breakthrough Cancer Treatment Success
01/07/2025
4
Acquisition by Springer Graig of 70000 shares of Hoth Therapeutics at 1.55 subject to Rule 16b-3
01/14/2025
5
Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025
01/17/2025
6
Hoth Therapeutics regains compliance with Nasdaq
01/24/2025
7
Hoth Therapeutics Partners with OnTargetx RD to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic
02/10/2025
8
Acquisition by Springer Graig of 33000 shares of Hoth Therapeutics at 2.11 subject to Rule 16b-3
02/18/2025
9
Insider Trading
02/26/2025
10
Hoth Therapeutics Announces Positive Results for HT-001 in Treating EGFR Inhibitor-Associated Papulopustular Eruptions Findings to be Presented at the American ...
03/05/2025
11
Hoth Therapeutics Receives Buy Rating from D. Boral Capital - Defense World
03/11/2025

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account